These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2369082)

  • 1. An antimelanoma-barley ribosome inactivating protein conjugate is cytotoxic to melanoma cells in vitro.
    Ovadia M; Hager CC; Oeltmann TN
    Anticancer Res; 1990; 10(3):671-5. PubMed ID: 2369082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.
    Thorpe PE; Blakey DC; Brown AN; Knowles PP; Knyba RE; Wallace PM; Watson GJ; Wawrzynczak EJ
    J Natl Cancer Inst; 1987 Nov; 79(5):1101-12. PubMed ID: 2890786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin.
    Rosenblum MG; Murray JL; Cheung L; Rifkin R; Salmon S; Bartholomew R
    Mol Biother; 1991 Mar; 3(1):6-13. PubMed ID: 1906286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cytotoxic effects of immunotoxin--monoclonal anti-AFP-abrin-A chain conjugate on several human hepatoma cell lines.
    Chow LP; Chang KH; Lin JY
    Biochem Int; 1990 Oct; 22(1):95-102. PubMed ID: 1704234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates.
    Sivam G; Pearson JW; Bohn W; Oldham RK; Sadoff JC; Morgan AC
    Cancer Res; 1987 Jun; 47(12):3169-73. PubMed ID: 3495329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of blue-sepharose for purification of immunotoxin containing type 1 ribosome-inactivating protein, gelonin.
    Masuda K; Hirano K; Takagishi Y
    Biomed Chromatogr; 1994; 8(1):9-13. PubMed ID: 7510554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotoxins to a human melanoma-associated antigen: resistance to pokeweed antiviral protein conjugates in vitro.
    Morgan AC; Bordonaro J; Pearson JW; Sivam G
    J Natl Cancer Inst; 1987 Jun; 78(6):1101-6. PubMed ID: 3473251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.
    Godal A; Fodstad O; Morgan AC; Pihl A
    J Natl Cancer Inst; 1986 Dec; 77(6):1247-53. PubMed ID: 3491924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new 'solid phase' procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates).
    Dosio F; Brusa P; Delprino L; Ceruti M; Grosa G; Cattel L; Bolognesi A; Barbieri L
    Farmaco; 1993 Jan; 48(1):105-15. PubMed ID: 8457275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
    Hirota N; Ueda M; Ozawa S; Abe O; Shimizu N
    Cancer Res; 1989 Dec; 49(24 Pt 1):7106-9. PubMed ID: 2555059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.
    Thorpe PE; Wallace PM; Knowles PP; Relf MG; Brown AN; Watson GJ; Knyba RE; Wawrzynczak EJ; Blakey DC
    Cancer Res; 1987 Nov; 47(22):5924-31. PubMed ID: 3499221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichosanthin-monoclonal antibody conjugate specifically cytotoxic to human hepatoma cells in vitro.
    Wang QC; Ying WB; Xie H; Zhang ZC; Yang ZH; Ling LQ
    Cancer Res; 1991 Jul; 51(13):3353-5. PubMed ID: 1647265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro and in vivo activity of a hybrid composed of ricin B chain-barley ribosome-inactivating protein.
    Ovadia M; Wiley RG; Hager C; LaRocca C; Oeltmann TN
    Arch Biochem Biophys; 1988 Jul; 264(1):168-75. PubMed ID: 3164992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans.
    Siena S; Bregni M; Formosa A; Brando B; Marenco P; Lappi DA; Bonadonna G; Gianni AM
    Cancer Res; 1989 Jun; 49(12):3328-32. PubMed ID: 2785850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of Moschatin, a novel type I ribosome-inactivating protein from the mature seeds of pumpkin (Cucurbita moschata), and preparation of its immunotoxin against human melanoma cells.
    Xia HC; Li F; Li Z; Zhang ZC
    Cell Res; 2003 Oct; 13(5):369-74. PubMed ID: 14672560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Jan; 44(1):201-8. PubMed ID: 6140077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of positive charge of lysine residue on ribosome-inactivating property of gelonin.
    Singh RC; Alam A; Singh V
    Indian J Biochem Biophys; 2001 Oct; 38(5):309-12. PubMed ID: 11886078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo efficacy of heat shock protein specific immunotoxins on human tumor cells.
    Piselli P; Vendetti S; Poccia F; Cicconi R; Mattei M; Bolognesi A; Stirpe F; Colizzi V
    J Biol Regul Homeost Agents; 1995; 9(2):55-62. PubMed ID: 9127634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.